Reportlinker Adds Orphan Drugs in Asia 2011
NEW YORK, May 23, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Orphan Drugs in Asia 2011
While orphan drug laws in Asia may provide benefits for companies registering new drugs, such as marketing exclusivity, an expedited registration process, and a reduction in the number of clinical trials required, each registration process is unique and can pose a variety of challenges. This report reviews the orphan drug regulations throughout Asia and discusses various business issues related to orphan drugs in Asia. Lists of approved orphan drugs in Asia and orphan drug associations are also included.
To order this report:
Drug and Medication Industry: Orphan Drugs in Asia 2011
Drug and Medication Business News
More áMarket Research Report
Check our áCompany Profile, SWOT and Revenue Analysis!
Contact Nicolas BombourgReportlinkerEmail: firstname.lastname@example.orgUS: (805)652-2626Intl: +1 805-652-2626